Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3184
Selected: 0
NCT IDTitle
NCT05084391Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)
NCT05239403Association Between Gut Microbiome and Dietary Determinants and Vaccine Response
NCT05124743HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
NCT02530515Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
NCT04435691Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia
NCT04746235Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
NCT03587662Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
NCT02530489Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
NCT02420860Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00507923Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer
NCT00508170Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
NCT05411718A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
NCT06875882Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomarker Analysis and Validated Questionnaires
NCT06445959Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
NCT00493688A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
NCT00674479INCB018424 in Patients With Advanced Hematologic Malignancies
NCT06006286A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
NCT04604522Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
NCT07193550A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
NCT01003054Autologous Transplantation for Chronic Myelogenous Leukemia
NCT02502786Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
NCT01846286Neuropathic Pain in Head and Neck Cancer
NCT05102656Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
NCT00481286Improving Outcomes Using Collaborative Group Clinics to Empower Older Patients
NCT01515527Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
NCT00477256School Reintegration Outcomes in Pediatric Cancer Patients
NCT07191496Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
NCT01262027TKI258 for Metastatic Inflammatory Breast Cancer Patients
NCT02774759Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers
NCT05137262A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
NCT00386373Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
NCT01311856Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors
NCT00254397Melanoma Vaccine With Peptides and Leuprolide
NCT00059618PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
NCT01328860Autologous Stem Cells for Spinal Cord Injury (SCI) in Children
NCT00924820A Pilot Study of Bevacizumab for Neoplastic Meningitis
NCT00038415A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach
NCT05053113Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
NCT04239976Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
NCT03222076Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
NCT06263491Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
NCT00329043Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
NCT05880849Choline Effects - Pre-symptomatic AD
NCT00038389Study of Vioxx and Radiation Therapy for Brainstem Glioma
NCT02511600Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
NCT06327100Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
NCT04701307Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas
NCT02199184Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00427791Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
NCT02027935CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma